MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
ArriVent BioPharma, Inc. Common Stock

AVBP

#2111
ArriVent BioPharma, Inc. Common Stock
22.97
+0.22%
Sector:
Básica:
Profit Currency:
Rango diario
22.93
22.97
Rango anual
15.47
26.00
Cambio diario
+0.22%
Monthly Change
-1.20%
6 month change
+19.57%
Cambio anual
-4.01%
Cierres anteriores
22.92
Open
22.93
Bid
Ask
Low
22.93
High
22.97
Volumen
76
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. AVBP
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Noticias

Investing Investing
AVBP
2026.01.16
Cantor Fitzgerald, ArriVent hissesi için Ağırlık Artırma notunu yineledi
Investing Investing
AVBP
2026.01.16
ArriVent stock rating reiterated as Overweight by Cantor Fitzgerald
Investing Investing
AVBP
2026.01.06
Oppenheimer, ArriVent BioPharma hissesi için Outperform notunu yineledi
Investing Investing
AVBP
2026.01.06
Oppenheimer reiterates Outperform rating on ArriVent BioPharma stock
Seeking Alpha Seeking Alpha
AVBP
2026.01.04
ArriVent BioPharma (AVBP): Its Leading Asset, Furmonertinib, Supports A Cautious Buy
Seeking Alpha Seeking Alpha
AVBP
2025.12.25
ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts (NASDAQ:AVBP)
Investing Investing
AVBP
2025.12.22
Cantor Fitzgerald, ArriVent BioPharma hissesini Ağırlık Üstü tavsiyesiyle takibe aldı
Investing Investing
AVBP
2025.12.22
Cantor Fitzgerald initiates ArriVent BioPharma stock with Overweight rating
Investing Investing
AVBP
2025.12.22
ArriVent, akciğer kanseri ilacı için önemli faz 3 çalışmasında ilk hastaya doz verdi
Investing Investing
AVBP
2025.12.22
ArriVent doses first patient in pivotal phase 3 trial for lung cancer drug
Investing Investing
AVBP
2025.12.10
BTIG, ArriVent BioPharma’ya onkoloji potansiyeli nedeniyle Al tavsiyesi verdi
Investing Investing
AVBP
2025.12.10
ArriVent BioPharma stock initiated with Buy rating at BTIG on oncology potential

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd